These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1446957)

  • 1. Morning vs evening effects of intrapulmonary administration of heparin in healthy men.
    Markiewicz A; Tausz B; Zahorska-Markiewicz B; Nawrot J
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):400-4. PubMed ID: 1446957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin as a therapy for atherosclerosis: preliminary observations on the intrapulmonary administration of low-dose heparin in the morning versus evening gauged by its effect on blood variables.
    Kanabrocki EL; Sothern RB; Bremner WF; Gruber SA; Scheving LE; Bushnell DL; Ryan M; Rubnitz ME; Fabbrini N; Lampo S
    Chronobiol Int; 1991; 8(3):210-33. PubMed ID: 1794159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
    Grimaudo V; Omri A; Kruithof EK; Hauert J; Bachmann F
    Thromb Haemost; 1988 Jun; 59(3):388-91. PubMed ID: 2847348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrono-pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteers.
    Mismetti P; Reynaud J; Tardy-Ponce B; Laporte-Simitsidis S; Scully M; Goodwyn C; Queneau P; Decousus H
    Thromb Haemost; 1995 Aug; 74(2):660-6. PubMed ID: 8585003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological rhythm and thromboembolic disease. Physiological, epidemiological and pharmacological aspects].
    Decousus H; Ollagnier M; Jaubert J; Perpoint B; Hocquart J; Queneau P
    Pathol Biol (Paris); 1987 Jun; 35(6):985-90. PubMed ID: 3306580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
    Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
    Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of evening vs morning thyroxine ingestion on serum thyroid hormone profiles in hypothyroid patients.
    Bolk N; Visser TJ; Kalsbeek A; van Domburg RT; Berghout A
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):43-8. PubMed ID: 17201800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of serum TSH level during oral glucose tolerance test: comparison of morning and evening test with plain circadian TSH rhythm.
    Langer P; Martino E; Ksinantova L; Glasso L; Vigas M
    Endocr Regul; 2000 Sep; 34(3):145-50. PubMed ID: 11074659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects.
    Brunner-Ziegler S; Jilma B; Schörgenhofer C; Winkler F; Jilma-Stohlawetz P; Koppensteiner R; Quehenberger P; Seger C; Weigel G; Griesmacher A; Brunner M
    J Thromb Haemost; 2016 Feb; 14(2):316-23. PubMed ID: 26644369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotherapeutic study of furosemide in hypertensive subjects: a preliminary report.
    Fujimura A; Ohashi K; Ebihara A
    Int J Clin Pharmacol Res; 1991; 11(2):67-73. PubMed ID: 1879991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension.
    Smolensky MH; Hermida RC; Portaluppi F
    Chronobiol Int; 2007; 24(1):171-81. PubMed ID: 17364587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of heparin and its pharmacodynamic effect on plasma lipoprotein lipase activity and coagulation in healthy horses.
    McCann ME; Watson TD; Boudinot FD; Moore JN
    Am J Vet Res; 1995 Aug; 56(8):1070-4. PubMed ID: 8533979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal rhythm in anticoagulant effect of heparin during a low dose constant rate infusion. A study in healthy volunteers.
    Krulder JW; de Boer A; van den Besselaar AM; Cohen AF; Schoemaker HC; Briët E; Meinders AE
    Thromb Haemost; 1992 Jul; 68(1):30-2. PubMed ID: 1514169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecological surgery patients.
    Palareti G; Legnani C; Bianchini B; Guazzaloca G; Maccaferri M; Marabini A; De Iaco P; Marcozzi S; Mancini L; Orlandi C
    Int Angiol; 1989; 8(1):47-52. PubMed ID: 2768958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response relationships of anticoagulant activities after subcutaneous administration of two low molecular weight heparins in healthy individuals.
    Hellstern P; Kiehl R; von Blohn G; Köhler M; Meierhenrich U; Wenzel E
    Thromb Haemost; 1986 Oct; 56(2):225-8. PubMed ID: 3810557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
    Maurin N; Ballmann M
    Clin Nephrol; 1988 Jul; 30(1):35-41. PubMed ID: 3061692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.